Brief: Janux Therapeutics Q3 Basic EPS USD -0.25

Janux Therapeutics

07/11/2023 21:01

Nov 07 (Reuters) - Janux Therapeutics Q3 net income USD -11.568 million.
* Q3 operating expenses USD 18.33 million
* Q3 operating income USD -15.813 million
* Q3 collaboration revenue USD 2.517 million